Keyword: Amylin Pharmaceuticals
News
11.06.2013
- A former Bristol-Myers Squibb finance executive on Monday pleaded guilty to an insider trading charge, admitting to buying stock options in a biotechnology company that the...
Plant Construction & Process Technology
25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
News
03.08.2012
- Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...
News
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
News
12.07.2012
- AstraZeneca has clinched two new deals in neuroscience, underlining the drugmaker's increasing reliance on external projects to refill a sparse pipeline as it tests a new low-cost...
News
20.04.2012
- Watchdog group Public Citizen urged U.S. regulators to withdraw approval of Novo Nordisk's diabetes drug Victoza, saying it increases the risk of serious health problems like...
News
28.03.2012
- Shares of Amylin Pharmaceuticals rose as much as 51% on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers...
News
17.05.2011
- Amylin Pharmaceuticals is suing longtime diabetes-drug partner Eli Lilly over its plans to help market a rival product with another company. Lilly helps the smaller Amylin sell the...
